Home › Funds › Paradigm Biocapital Advisors LP › IVA

Paradigm Biocapital Advisors LP position in IVA

INVENTIVA SA · Health Care

Paradigm Biocapital Advisors LP reported holding 808,176 shares of IVA (INVENTIVA SA) in its Q3 2026 13F filing — a position valued at US$3.0M, representing 0.06% of its reported portfolio and ranking #29 among its reported holdings. Paradigm Biocapital Advisors LP has disclosed IVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

Latest position (Q3 2026)808.18K sh
Reported value held$2.98M
Portfolio Weight0.06%
First reportedQ4 2025
Last changeReduce
Updated2026-11-16

Last updated: 2026-11-16 · Source: SEC EDGAR Form 13F-HR

How Paradigm Biocapital Advisors LP's IVA position evolved

Paradigm Biocapital Advisors LP first disclosed a stake in IVA in Q4 2025 at 4,000,000 shares (US$18.6M). The position peaked in Q1 2026 at 4,000,000 shares, worth US$22.2M. Across 4 filings, Paradigm Biocapital Advisors LP increased the stake 0 time(s), trimmed it 1 time(s) and left it unchanged 2 time(s). The most recent filing (Q3 2026) shows 808,176 shares valued at US$3.0M — a reduction of -3,191,824 shares quarter over quarter.. Notable position changes include a 80% trim in Q3 2026 (shares were roughly flat over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q4 2025 4.00M $18.60M New
Q1 2026 4.00M $22.20M Hold
Q2 2026 4.00M $15.12M Hold
Q3 2026 808.18K $2.98M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About IVA and 13F data

IVA (INVENTIVA SA) is a Health Care company. 81 other funds we track also report a position in IVA — the largest reported positions include Caligan Partners LP (US$30.9M), Samsara BioCapital, LLC (US$23.9M), Andera Partners (US$13.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding IVA

All IVA fund holders →

FAQ

How long has Paradigm Biocapital Advisors LP held IVA?

Paradigm Biocapital Advisors LP has disclosed IVA holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Paradigm Biocapital Advisors LP's current position in IVA?

As of Q3 2026, Paradigm Biocapital Advisors LP holds 808.18K shares of IVA (INVENTIVA SA), valued at $2.98M, representing 0.06% of its reported portfolio and ranking #29.

Has Paradigm Biocapital Advisors LP been buying or selling IVA?

In the latest 13F filing (Q3 2026), Paradigm Biocapital Advisors LP reduced its position in IVA. The position peaked in Q1 2026 at 4.00M shares.

Which other funds hold IVA?

Other major institutional holders of IVA include Caligan Partners LP, Samsara BioCapital, LLC, Andera Partners, among 81 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.